$4.15
0.73% day before yesterday
Nasdaq, May 30, 10:02 pm CET
ISIN
US56400P7069
Symbol
MNKD
Sector
Industry

MannKind Corporation Stock price

$4.15
-0.89 17.66% 1M
-2.44 37.03% 6M
-2.28 35.46% YTD
-0.35 7.78% 1Y
-0.29 6.53% 3Y
+2.71 188.19% 5Y
-21.65 83.91% 10Y
Nasdaq, Closing price Fri, May 30 2025
+0.03 0.73%
ISIN
US56400P7069
Symbol
MNKD
Sector
Industry

Key metrics

Market capitalization $1.26b
Enterprise Value $1.37b
P/E (TTM) P/E ratio 41.50
EV/FCF (TTM) EV/FCF 62.78
EV/Sales (TTM) EV/Sales 4.60
P/S ratio (TTM) P/S ratio 4.24
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 32.48%
Revenue (TTM) Revenue $297.60m
EBIT (operating result TTM) EBIT $81.08m
Free Cash Flow (TTM) Free Cash Flow $21.82m
Cash position $181.54m
EPS (TTM) EPS $0.10
P/E forward 21.36
P/S forward 3.96
EV/Sales forward 4.30
Short interest 8.62%
Show more

Is MannKind Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

MannKind Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a MannKind Corporation forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a MannKind Corporation forecast:

Buy
100%

Financial data from MannKind Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
298 298
32% 32%
100%
- Direct Costs 72 72
11% 11%
24%
225 225
41% 41%
76%
- Selling and Administrative Expenses 97 97
5% 5%
33%
- Research and Development Expense 47 47
31% 31%
16%
89 89
149% 149%
30%
- Depreciation and Amortization 8.12 8.12
68% 68%
3%
EBIT (Operating Income) EBIT 81 81
162% 162%
27%
Net Profit 30 30
252% 252%
10%

In millions USD.

Don't miss a Thing! We will send you all news about MannKind Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MannKind Corporation Stock News

Neutral
GlobeNewsWire
5 days ago
WESTLAKE VILLAGE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will team up with NTT INDYCAR SERIES driver Conor Daly, who is living with Type 1 diabetes (T1D) for a one-of-a-kind experience with Detroit area youth and families during the week of the Chevrolet Detroit Grand Prix in downtown Detroit.
Neutral
Seeking Alpha
6 days ago
MannKind's stock decline is likely due to concerns over Tyvaso DPI competition from Liquidia, but I believe these fears are exaggerated. Tyvaso DPI provides MannKind with a stable revenue base, supporting its focused pipeline and future growth opportunities. MannKind's Technosphere technology holds promise for additional partnerships beyond United Therapeutics, enhancing long-term potential.
Neutral
GlobeNewsWire
19 days ago
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced its participation at the upcoming investor conferences. MannKind's Chief Executive Officer Michael Casta...
More MannKind Corporation News

Company Profile

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.

Head office United States
CEO Michael Castagna
Employees 405
Founded 1991
Website mannkindcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today